Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Cal Gary who wrote (8545)	1/28/2002 1:24:17 PM
From: Mark Bartlett	Respond to of 14101

Cal Gary, <<Assume he knows what analysis is done at the end, all checkpoints should be in place to follow protocol or process.>> Bottom line -- it take time even if you have everything in place. Many here are assuming the worst i.e., results are marginal to poor, hence the delay. What if it is just the opposite -- i.e, they are exceptional and that is causing the delay. I have no idea what way it is going to fall, but either way they have to be very careful with the analysis. Also -- there were about 25 centers running these trials all over the US and Canada. That means reviewing the data collection nuances from many different participants. Sure -- they all have the same forms to fill out under the same protocol, but there will be human variances within those parameters and they will have to be accounted for. My own personal feeling is we will have a drug and likely a pretty decent one -- but life is full of surprises. MB